C

Chatham-Kent Clinical Trials Research Centre | Chatham, Canada

Research site

(Unclaimed)

Location

240 Grand Ave W Suite #214, Chatham, Ontario, Canada

Site insights

Top conditions

Top treatments

BI 409306

BI 425809

Donepezil

SPD489

Brexpiprazole

Lisdexamfetamine Dimesylate

Troriluzole

JNJ-55308942

Vortioxetine

PF-05212377

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compu...

Enrolling

Obsessive-Compulsive Disorder

Drug: Troriluzole

Drug: Placebo

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only

Obsessive Compulsive Disorder

Drug: Troriluzole (BHV-4157)